Two Sigma Advisers’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-133,700
| Closed | -$1.09M | – | 2537 |
|
|
2024
Q4 | $1.09M | Buy |
+133,700
| New | +$1.09M | ﹤0.01% | 1416 |
|
|
2024
Q3 | – | Sell |
-16,300
| Closed | -$168K | – | 2464 |
|
|
2024
Q2 | $168K | Sell |
16,300
-35,300
| -68% | -$364K | ﹤0.01% | 2247 |
|
|
2024
Q1 | $548K | Buy |
51,600
+28,900
| +127% | +$307K | ﹤0.01% | 1835 |
|
|
2023
Q4 | $207K | Buy |
+22,700
| New | +$207K | ﹤0.01% | 2220 |
|
|
2023
Q1 | – | Sell |
-14,800
| Closed | -$166K | – | 2721 |
|
|
2022
Q4 | $166K | Sell |
14,800
-9,300
| -39% | -$104K | ﹤0.01% | 2222 |
|
|
2022
Q3 | $267K | Sell |
24,100
-8,800
| -27% | -$97.5K | ﹤0.01% | 2098 |
|
|
2022
Q2 | $278K | Sell |
32,900
-5,100
| -13% | -$43.1K | ﹤0.01% | 2146 |
|
|
2022
Q1 | $517K | Buy |
38,000
+5,900
| +18% | +$80.3K | ﹤0.01% | 1972 |
|
|
2021
Q4 | $631K | Buy |
32,100
+15,700
| +96% | +$309K | ﹤0.01% | 1799 |
|
|
2021
Q3 | $526K | Sell |
16,400
-9,100
| -36% | -$292K | ﹤0.01% | 1910 |
|
|
2021
Q2 | $863K | Sell |
25,500
-5,900
| -19% | -$200K | ﹤0.01% | 1698 |
|
|
2021
Q1 | $1.18M | Buy |
+31,400
| New | +$1.18M | ﹤0.01% | 1565 |
|